Adipose Derived Stem Cell Therapy Market
According to Intent Market Research, the Adipose Derived Stem Cell Therapy Market is expected to grow from USD 12.3 billion in 2023 at a CAGR of 11.7% to touch USD 26.6 billion by 2030. The Adipose Derived Stem Cell Therapy Market is dominated by key players such as Anterogen Co., Ltd., Athersys, Inc., Celltex Therapeutics Corporation, ExCellThera, Inc., Haplogen GmbH, IsuAbxis and Mesoblast Ltd.